JPY 908.0
(-0.33%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.09 Billion JPY | -37.26% |
2022 | 1.75 Billion JPY | -12.64% |
2021 | 1.99 Billion JPY | 34.14% |
2020 | 1.45 Billion JPY | -19.0% |
2019 | 1.83 Billion JPY | 31.57% |
2018 | 1.4 Billion JPY | -30.78% |
2017 | 2.02 Billion JPY | 13.78% |
2016 | 1.78 Billion JPY | 141.67% |
2015 | 721.37 Million JPY | -25.12% |
2014 | 975.95 Million JPY | 26.69% |
2013 | 791.08 Million JPY | 25.82% |
2012 | 589.01 Million JPY | 107.06% |
2011 | 212.1 Million JPY | -43.93% |
2010 | 525.72 Million JPY | -60.42% |
2009 | 754.69 Million JPY | 73.94% |
2008 | 146 Million JPY | -24.31% |
2007 | 216 Million JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 266.5 Million JPY | 254.89% |
2023 Q4 | 229.99 Million JPY | -15.33% |
2023 Q1 | 211.61 Million JPY | 235.0% |
2023 Q2 | 280.2 Million JPY | 32.41% |
2023 FY | - JPY | -37.26% |
2023 Q3 | 271.64 Million JPY | -3.05% |
2022 Q1 | 462.86 Million JPY | 42.05% |
2022 Q2 | 549.69 Million JPY | 18.76% |
2022 FY | - JPY | -12.64% |
2022 Q3 | 275.51 Million JPY | -49.88% |
2022 Q4 | -156.74 Million JPY | -156.89% |
2021 Q4 | 325.84 Million JPY | 24.35% |
2021 Q1 | 586.06 Million JPY | 46.84% |
2021 FY | - JPY | 34.14% |
2021 Q2 | 325.29 Million JPY | -44.49% |
2021 Q3 | 262.03 Million JPY | -19.45% |
2020 Q4 | 399.12 Million JPY | -11.97% |
2020 FY | - JPY | -19.0% |
2020 Q3 | 453.38 Million JPY | 90.2% |
2020 Q2 | 238.37 Million JPY | 920.23% |
2020 Q1 | -29.06 Million JPY | -105.99% |
2019 Q4 | 485.2 Million JPY | 72.5% |
2019 Q1 | 352.88 Million JPY | 170.22% |
2019 Q2 | 266.08 Million JPY | -24.6% |
2019 Q3 | 281.27 Million JPY | 5.71% |
2019 FY | - JPY | 31.57% |
2018 Q2 | 244.09 Million JPY | -35.32% |
2018 Q3 | 219.63 Million JPY | -10.02% |
2018 Q4 | 130.59 Million JPY | -40.54% |
2018 FY | - JPY | -30.78% |
2018 Q1 | 377.38 Million JPY | -24.95% |
2017 Q1 | 388.49 Million JPY | -26.17% |
2017 Q3 | 400.29 Million JPY | -15.02% |
2017 Q2 | 471.03 Million JPY | 21.25% |
2017 FY | - JPY | 13.78% |
2017 Q4 | 502.85 Million JPY | 25.62% |
2016 Q3 | 414.14 Million JPY | 122.31% |
2016 Q2 | 186.29 Million JPY | -56.65% |
2016 FY | - JPY | 141.67% |
2016 Q4 | 526.22 Million JPY | 27.06% |
2016 Q1 | 429.7 Million JPY | 522.01% |
2015 FY | - JPY | -25.12% |
2015 Q1 | 238.94 Million JPY | -8.67% |
2015 Q2 | 43.71 Million JPY | -81.71% |
2015 Q3 | 191.01 Million JPY | 336.98% |
2015 Q4 | 69.08 Million JPY | -63.83% |
2014 Q2 | 186.68 Million JPY | 293.06% |
2014 Q1 | 47.49 Million JPY | -71.35% |
2014 FY | - JPY | 26.69% |
2014 Q4 | 261.63 Million JPY | -13.79% |
2014 Q3 | 303.46 Million JPY | 62.56% |
2013 FY | - JPY | 25.82% |
2013 Q4 | 165.79 Million JPY | -26.88% |
2013 Q3 | 226.74 Million JPY | 167.75% |
2013 Q2 | 84.68 Million JPY | -40.76% |
2013 Q1 | 142.96 Million JPY | -10.53% |
2012 FY | - JPY | 107.06% |
2012 Q4 | 159.79 Million JPY | -18.59% |
2012 Q1 | 149.58 Million JPY | 7425.17% |
2012 Q2 | -37.3 Million JPY | -124.94% |
2012 Q3 | 196.29 Million JPY | 626.15% |
2011 Q4 | -2.04 Million JPY | -113.57% |
2011 Q2 | 841 Thousand JPY | -98.86% |
2011 FY | - JPY | -43.93% |
2011 Q1 | 74.08 Million JPY | 130.02% |
2011 Q3 | 15.05 Million JPY | 1689.66% |
2010 Q4 | 32.2 Million JPY | -83.94% |
2010 Q2 | 112.29 Million JPY | -39.16% |
2010 Q1 | 184.57 Million JPY | -75.69% |
2010 FY | - JPY | -60.42% |
2010 Q3 | 200.49 Million JPY | 78.54% |
2009 Q2 | 216.42 Million JPY | -6.7% |
2009 FY | - JPY | 73.94% |
2009 Q4 | 759.21 Million JPY | 482.58% |
2009 Q3 | 130.31 Million JPY | -39.79% |
2009 Q1 | 231.96 Million JPY | -52.64% |
2008 Q3 | 40.94 Million JPY | -59.51% |
2008 Q4 | 489.74 Million JPY | 1096.02% |
2008 FY | - JPY | -24.31% |
2008 Q2 | 101.14 Million JPY | 0.0% |
2007 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | 31.07% |
Euglena Co., Ltd. | 676 Million JPY | -61.915% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | 44.293% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -96.947% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | 72.725% |
Kao Corporation | 154.49 Billion JPY | 99.292% |
Niitaka Co., Ltd. | 1.36 Billion JPY | 20.078% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 97.76% |
Shiseido Company, Limited | 106.46 Billion JPY | 98.972% |
Lion Corporation | 42.31 Billion JPY | 97.413% |
Mandom Corporation | 6.69 Billion JPY | 83.661% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -351.173% |
Milbon Co., Ltd. | 7.8 Billion JPY | 85.968% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | 15.058% |
Fancl Corporation | 16.6 Billion JPY | 93.408% |
KOSÉ Corporation | 26.85 Billion JPY | 95.925% |
Cota Co., Ltd. | 2.26 Billion JPY | 51.75% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 183.279% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -536.931% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 95.277% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 91.061% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -782.698% |
Almado, Inc. | 983.21 Million JPY | -11.323% |
I-ne CO., LTD. | 4.7 Billion JPY | 76.712% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 274.569% |
Liberta Co.,Ltd. | 318.19 Million JPY | -243.989% |
AXXZIA Inc. | 1.28 Billion JPY | 14.921% |
S.T. Corporation | 2.62 Billion JPY | 58.319% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 96.545% |
Earth Corporation | 10.6 Billion JPY | 89.682% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 290.694% |
Ya-Man Ltd. | 1.43 Billion JPY | 23.819% |
MTG Co., Ltd. | 4.39 Billion JPY | 75.09% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | 81.159% |
SHOBIDO Corporation | 1.11 Billion JPY | 1.41% |
Artnature Inc. | 3.78 Billion JPY | 71.097% |
Pigeon Corporation | 15.8 Billion JPY | 93.075% |
Unicharm Corporation | 178.01 Billion JPY | 99.385% |
Paltac Corporation | 35.92 Billion JPY | 96.953% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | 66.68% |